Keck School of Medicine of USC | Neurology Department
Status and phase
Conditions
Treatments
About
The goal of this clinical trial is to learn about INS018_055 in adults with Idiopathic Pulmonary Fibrosis (IPF).
The primary objective is to evaluate the safety and tolerability of INS018_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Meeting all of the following criteria during the screening period:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Yichen Liu; Franz Espiritu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal